4-Chloro-alpha-pyrrolidinovalerophenone

4-Chloro-*alpha*-pyrrolidinovalerophenone
Clinical data
Routes of; administration	Oral, intranasal, intravenous, rectal,
Legal status
Legal status	US: Schedule I ;
Identifiers
	IUPAC name 1-(4-Chlorophenyl)-2-(1-pyrrolidinyl)-1-pentanone;
ChemSpider	52085629 ;
UNII	DX2R2SJT7G;
CompTox Dashboard (EPA)	DTXSID001014167 ;
Chemical and physical data
Formula	C15H20ClNO
Molar mass	265.78 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCC(C(=O)c1ccc(cc1)Cl)N2CCCC2;
	InChI InChI=1S/C15H20ClNO/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11H2,1H3; Key:NIGBFBTVONRYQN-UHFFFAOYSA-N [1];

4-Chloro-alpha-pyrrolidinovalerophenone (also known as 4-chloro-alpha-pyrrolidinopentiophenone, 4-chloro-α-PVP, 4Cl-PVP, or 4C-PVP) is an emerging recreational designer drug of the pyrrolidinophenone class, similar in structure to alpha-pyrrolidinopentiophenone (α-PVP). The pharmacology and toxicity of this compound is unknown.[2]

In the United States, 4-chloro-α-PVP is a Schedule I Controlled Substance.[3]

References

"Product Information Insert" (PDF). Cayman Chemical. May 1, 2016. Archived (PDF) from the original on May 7, 2016. Retrieved May 1, 2016.
"Product Information". Cayman Chemical. May 1, 2016. Archived from the original on May 7, 2016. Retrieved May 1, 2016.
"Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-29.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "Product Information Insert" (PDF). Cayman Chemical. May 1, 2016. Archived (PDF) from the original on May 7, 2016. Retrieved May 1, 2016.

[2] "Product Information". Cayman Chemical. May 1, 2016. Archived from the original on May 7, 2016. Retrieved May 1, 2016.

[3] "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-29.